A third producer of oral cholera vaccine has been approved that is expected to provide 3 million doses in 2016, doubling the world’s stockpile against a disease that can kill within hours.
EuBiologics, a South Korea-based producer, joins Shantha Biotechnics of Sanofi Pasteur as a pre-qualified supplier.
The third producer, which currently does not have doses in the stockpile, is Sweden’s Crucell.
It has future potential in the next 3-4 years for a much greater increase in vaccine production.
A vaccine campaign will begin in Haiti this month, targeting some 240,000 people.